Behavioral effects of levetiracetam mitigated by pyridoxine.
Department of Child & Adolescent Psychiatry, New York University School of Medicine, New York, NY, USA.
Glen P
GP
Davis
John T
JT
McCarthy
David B
DB
Magill
Barbara
B
Coffey
D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001526:Behavioral Symptoms / Q000139:chemically induced* / Q000523:psychology; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D000077287:Levetiracetam; D008297:Male; D010889:Piracetam / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011736:Pyridoxine / Q000008:administration & dosage*; D012640:Seizures / Q000188:drug therapy; D014803:Vitamin B Complex / Q000008:administration & dosage*
D000927:Anticonvulsants; D014803:Vitamin B Complex; D000077287:Levetiracetam; D011736:Pyridoxine; D010889:Piracetam